PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PDS Biotechnology Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013959
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunotherapies and t-cell vaccines. Its products are used for treatment of HPV pre-cancer, head and neck cancer, ovarian cancer, pandemic influenza, cervical cancer and breast cancer, among others. The company also partners with cancer research institutes and biotechnology companies. PDS Biotechnology is headquartered in North Brunswick, New Jersey, the US.

PDS Biotechnology Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PDS Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PDS Biotech Raises USD1 Million in Venture Financing 10
PDS Biotech Raises Funds Through Venture Financing 11
PDS Biotech Raises Funds Through Venture Financing 12
Private Equity 13
NetScientific Invests in PDS Biotech 13
Partnerships 14
PDS Biotech Enters into Agreement with Merck 14
PDS Biotechnology Enters into R&D Agreement with National Cancer Institute 15
Licensing Agreements 16
PDS Biotechnology Enters Into Licensing Agreement With Merck For Versamune 16
PDS Biotechnology Corp – Key Competitors 17
PDS Biotechnology Corp – Key Employees 18
PDS Biotechnology Corp – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Jan 20, 2016: Immunotherapy Company PDS Biotechnology Strengthens Senior Management Team, Adds Two Drug Development Executives 20
Clinical Trials 21
Jun 07, 2016: PDS Biotechnology: CEO Frank Bedu-Addo Presenting at BIO 2016 21
Apr 13, 2016: PDS Biotechnology Reports Positive Phase 1 Study Results for PDS0101 Immunotherapy for HPV-Related Cancers 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Key Facts 2
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PDS Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PDS Biotechnology Corp, Deals By Therapy Area, 2011 to YTD 2017 8
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PDS Biotech Raises USD1 Million in Venture Financing 10
PDS Biotech Raises Funds Through Venture Financing 11
PDS Biotech Raises Funds Through Venture Financing 12
NetScientific Invests in PDS Biotech 13
PDS Biotech Enters into Agreement with Merck 14
PDS Biotechnology Enters into R&D Agreement with National Cancer Institute 15
PDS Biotechnology Enters Into Licensing Agreement With Merck For Versamune 16
PDS Biotechnology Corp, Key Competitors 17
PDS Biotechnology Corp, Key Employees 18

★海外企業調査レポート[PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sirti SpA:企業の戦略的SWOT分析
    Sirti SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Boise Cascade Company:企業の戦略・SWOT・財務情報
    Boise Cascade Company - Strategy, SWOT and Corporate Finance Report Summary Boise Cascade Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Barclaycard:企業の戦略・SWOT・財務分析
    Barclaycard - Strategy, SWOT and Corporate Finance Report Summary Barclaycard - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Urban One Inc (UONEK):企業の財務・戦略的SWOT分析
    Urban One Inc (UONEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Charoen Pokphand Foods Public Company Limited:企業の戦略・SWOT・財務情報
    Charoen Pokphand Foods Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Charoen Pokphand Foods Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Robert Half International Inc (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Alviva Holdings Ltd (AVV):企業の財務・戦略的SWOT分析
    Alviva Holdings Ltd (AVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NetSuite Inc:企業の戦略的SWOT分析
    NetSuite Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Eni S.p.A:企業の戦略・SWOT・財務情報
    Eni S.p.A - Strategy, SWOT and Corporate Finance Report Summary Eni S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • DaVita Inc.:企業の戦略・SWOT・財務情報
    DaVita Inc. - Strategy, SWOT and Corporate Finance Report Summary DaVita Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Efore Oyj (EFO1V):企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Allahabad Bank (ALBK):企業の財務・戦略的SWOT分析
    Allahabad Bank (ALBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Keane Group Inc (FRAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Keane Group Inc (Keane Group) is an oil and gas company that offers integrated completion and drilling services. The company provides hydraulic fracturing services, engineered solutions, wire-line services, pressure pumping, cementing service, coiled tubing and well intervention services. It …
  • Suelopetrol CA SACA:企業の戦略的SWOT分析
    Suelopetrol CA SACA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Hunter Oil Corp (HOC):企業の財務・戦略的SWOT分析
    Summary Hunter Oil Corp (HOC), formerly Enhanced Oil Resources Inc is an oil and gas company that offers energy production programs. The company offers production and rehabilitation of its legacy oil fields through full cycle development. It also provides full cycle development services such as rese …
  • Pro-Dex Inc (PDEX):製品パイプライン分析
    Summary Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products comprise motion control, finished medical devices, plastic injection molding, micro air-motors, dental products, and torque wrenches. Its dental products include DLS handp …
  • Sekisui Diagnostics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sekisui Diagnostics LLC (Sekisui Diagnostics), a subsidiary of Sekisui Chemical Co Ltd, is a medical device company that develops, manufactures and supplies clinical diagnostic and research products. The company provides products such as coagulation, clinical chemistry, virotech products, OS …
  • Aminex PLC (AEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Aminex PLC (Aminex) is an oil and gas company that explores, develops and produces oil and gas reserves in Africa. The company provides assets such as Valeni field and Viktorovka field in Moldova; West Esh el Mellaha-2 in Egypt; and Kiliwani North development, Nyuni exploration, and Ruvuma e …
  • Chronos Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Chronos Therapeutics Ltd (Chronos) is a developer of medications for degenerative and behavioural diseases of the brain and nervous system. The company offers research and development, screening, discovery, repositioning and acquisition programs. Its pipeline products comprise RDC5 neurodege …
  • Abengoa SA (ABG)-エネルギー分野:企業M&A・提携分析
    Summary Abengoa, S.A. (Abengoa) is a manufacturer of applied engineering and equipment. The company provides integrated project solutions, including engineering and operation and maintenance services for conventional and renewable energy, infrastructure, and water desalination projects. Through long …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆